Severe asthma in the US population and eligibility for mAb therapy - 06/04/20
Doi : 10.1016/j.jaci.2019.12.009
Ayobami Akenroye, MD, MPH a 
, Meredith McCormack, MD, MHS b, Corinne Keet, MD, PhD a
, Meredith McCormack, MD, MHS b, Corinne Keet, MD, PhD a a Department of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md
b Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md
| This work was supported by the National Institute of Allergy and Infectious Diseases T32 Research Training Grant in Pediatric Allergy and Immunology (grant no. 2T32AI007007-41), and the Johns Hopkins University Provost’s Postdoctoral Award. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 145 - N° 4
P. 1295 - avril 2020 Regresar al número
Artículo precedente
- A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol
- Edwin H. Kim, Stacie M. Jones, A. Wesley Burks, Robert A. Wood, Scott H. Sicherer, Donald Y.M. Leung, Alice K. Henning, Robert W. Lindblad, Peter Dawson, Corinne Keet, Amy M. Scurlock, Marshall Plaut, Hugh A. Sampson
- Erythropoiesis defect observed in STAT3 GOF patients with severe anemia
- Andrea A. Mauracher, Julia J.M. Eekels, Janine Woytschak, Audrey van Drogen, Alessandra Bosch, Seraina Prader, Matthias Felber, Maximillian Heeg, Lennart Opitz, Johannes Trück, Silke Schroeder, Eva Adank, Adam Klocperk, Eugenia Haralambieva, Dieter Zimmermann, Sofia Tantou, Kosmas Kotsonis, Aikaterini Stergiou, Maria G. Kanariou, Stephan Ehl, Onur Boyman, Anna Sediva, Raffaele Renella, Markus Schmugge, Stefano Vavassori, Jana Pachlopnik Schmid
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?